DroidSurg Empowers Grassroots Orthopedics with Integrated Digital-Intelligent Surgical Solutions

As orthopedic surgery enters the era of digital intelligence, surgical robots are becoming a core force driving precision diagnosis and treatment as well as minimally invasive therapy. Driven by both technological iteration and clinical demand, the global orthopedic surgical robotics sector is rapidly gaining momentum. From spine to joint procedures, and from trauma care to sports medicine, robotic technology is gradually breaking the traditional over-reliance on surgeons’ experience, propelling surgical practices toward greater precision, enhanced safety, and minimal invasiveness.

However, the industry continues to face multiple challenges, including high technological barriers for equipment, a monopoly of imported products in the high-end market, and elevated equipment prices, which have significantly limited the application of such technologies in primary healthcare settings. Against this backdrop, a number of companies dedicated to breaking technological monopolies and promoting the digital and intelligent upgrading of domestically produced orthopedic solutions have emerged. Shanghai Zhuoxin Medical Technology Co., Ltd. (hereinafter referred to as “Zhuoxin Medical”) is a typical representative among them.

Zhuoxin Medical, as a leading company in intelligent medical equipment,Dedicated to the design, R&D, and commercialization of high-end medical equipment, including next-generation surgical robots, 3D imaging devices, AI-based surgical planning systems, and intelligent personalized rehabilitation solutions. We provide comprehensive preoperative, intraoperative, and postoperative solutions that transition from digitalization to intelligence, driving the holistic digital and intelligent upgrade of the healthcare industry.

Looking back to 2017, enthusiasm in the robotics sector continued to rise, while the demand for digital and intelligent transformation in traditional treatment and consumables fields became increasingly urgent. However, China’s orthopedic surgical robot industry was still in its early stages of technological breakthroughs and market cultivation. Core technologies and key components were heavily reliant on imports, with a very low localization rate. Market dominance was firmly held by international brands, creating a stark contrast with the industry’s pressing need for digital and intelligent transformation.

At that time, Professor Wang Shaobai, who was serving at Harvard University and Massachusetts General Hospital in the United States, was highly optimistic about the future development prospects of China’s intelligent medical equipment industry. As a jointly trained Ph.D. graduate of Harvard University, the Massachusetts Institute of Technology (MIT), and Massachusetts General Hospital, he had accumulated over a decade of experience in integrating medicine with engineering and translating research outcomes, particularly in the fields of biomechanics, digital orthopedics, surgical robots, and imaging equipment. To break the long-standing monopoly held by foreign technologies and strive to build a world-class competitive intelligent healthcare enterprise in China, he gave up his high-paying overseas position and returned to his homeland. Driven by profound scientific research expertise and deep patriotism, he founded Zhuoxin Medical.

Wang Shaobai, Ph.D., jointly trained by Harvard University, the Massachusetts Institute of Technology, and Massachusetts General Hospital,

Founder and General Manager of Shanghai Zhuoxin Medical Technology Co., Ltd.

Zhuoxin Medical adheres to the philosophy of “innovation-driven development,” centering on clinical needs and focusing on specific scenarios in clinical diagnosis and treatment to carry out product R&D and the translation of industry-academia-research achievements into clinical applications. Centered on the track of “digital and intelligent surgery,” the company builds a one-stop “comprehensive solution” for physicians, covering the entire diagnostic and therapeutic process—including preoperative diagnosis, intraoperative treatment, postoperative assessment, and rehabilitation. While improving surgical outcomes, it simplifies complex procedures and standardizes simple ones, assisting physicians in performing surgeries with greater precision and minimal invasiveness. This approach accelerates the dissemination and decentralization of high-quality medical resources, ultimately realizing the vision of “universal benefit for both patients and healthcare providers.”

The company’s headquarters is located in the Lingang Songjiang Technology City. Thanks to the comprehensive services provided by the Lingang Industrial Park in areas such as investment and financing matchmaking, enterprise reward applications, talent support, and rental incentives, the company successfully navigated numerous challenges during its early stages of development.

Since its establishment, Zhuoxin Medical has actively recruited, trained, and built a multidisciplinary team integrating medical and engineering expertise, forming an R&D team with extensive industry experience and innovative capabilities. Through years of research, development, and accumulation, the company has developed multiple core technologies in fields such as surgical robots, imaging equipment, and innovative consumables, primarily covering five major technology categories,Including image processing technology, surgical navigation and positioning technology, 3D visualization technology, robotic arm control technology, and surgical robot system design and integration technology.

Currently, Zhuoxin Medical has launched dozens of products, including spinal surgery robots, mobile 3D C-arms, AI-powered full-field digital radiography (DR) X-ray imaging systems, digital joint ligament examination devices, and joint motion function parameter detectors.

Currently, the vast majority of operating rooms still rely on two-dimensional fluoroscopy equipment. The resulting images suffer from issues such as overlap and projection distortion, and lack spatial depth information. Consequently, although surgeons may appear to have localized the target area, they actually need to adjust the equipment angle multiple times for multi-angle observation to confirm the position.

In contrast, the iteration of 3D technology is revolutionary. Taking Zhuoxin Medical’s 3D C-arm as an example, it not only achieves a breakthrough from 2D to 3D imaging but also enables efficient collaboration with robotic systems. By acquiring precise spatial information through 3D scanning, it can directly guide robots to accurately reach the target site.This “3D C-arm + surgical robot” combination represents not only a technological innovation but also constitutes an efficient, integrated solution.

Zhuoxin Medical 3D C-arm and Spinal Surgery Robot Scenario Diagram

Zhuoxin Medical's mobile 3D C-arm adopts an isocentric imaging design, featuring an ultra-large field of view and ultra-high-definition resolution.3D mode enables easy reconstruction of more than seven vertebral bodies, long-segment imaging can be completed in a single acquisition; supports high-speed volumetric scanning,Acquire 200° wide-range images in just 10 seconds, rapidly complete 3D reconstruction, and generate tomographic images.; The system can adaptively adjust the exposure dose based on the surgical site and patient thickness, and accurately identify and remove metal artifact interference, providing a clear imaging field for physicians to assess lesions and manipulate instruments. Its highly compatible modular design allows seamless integration with spinal surgery robots available on the market, offering critical imaging support for intraoperative precise positioning, path planning, and efficacy evaluation, thereby comprehensively ensuring surgical safety and efficiency.

According to the sci-tech novelty search report issued by the Shanghai Pudong Intellectual Property Technology Service Center, a third-party agency, Zhuoxin Medical’s 3D C-arm has reached an internationally advanced level in terms of comprehensive technology and application effectiveness, rivaling similar products from global industry giants. Professor Wang Shaobai, the founder, stated that Zhuoxin Medical’s 3D C-arm offers exceptional cost-effectiveness and has the potential to drive a widespread revolution in intraoperative imaging, transitioning from 2D to 3D, thereby enhancing the accessibility of intelligent imaging equipment in China.

Furthermore, Zhuoxin Medical has collaborated with Professor Zhao Jinzhong, Chief Scientist of the National Key R&D Program and Director of the National Orthopedic Medical Center at Shanghai Sixth People’s Hospital, to jointly develop a sports medicine surgical robot. This device provides personalized solutions to address the pain points and challenges inherent in traditional anterior cruciate ligament (ACL) reconstruction surgery. It integrates the entire workflow from preoperative planning and intraoperative execution to postoperative assessment, thereby enhancing surgical efficiency, shortening the learning curve for surgeons, reducing postoperative complications, and promoting functional recovery. The project has received numerous accolades, including the First Prize of the Shanghai Science and Technology Progress Award and the Excellence Award in the Pudong Division of the Shanghai Preliminary Round of the 5th “China Chuangyi” Innovation and Entrepreneurship Competition.

Professor Zhao Jinzhong’s Team Performs Anterior Cruciate Ligament Reconstruction Using a Sports Medicine Robot

Zhuoxin Medical's new-generation orthopedic platform robot is a universal solution in the field of orthopedics, applicable to spine, trauma, joint, and sports medicine surgeries.. The product is designed for the rapid, real-time localization of surgical instrument channels. By leveraging proprietary real-time automatic registration technology for intraoperative 3D imaging combined with infrared optical navigation principles, it quickly and accurately plans the surgical channel and drives a six-axis collaborative robot to the designated position via control software.Develop a universal platform for needle insertion, drilling, and osteotomy, creating a comprehensive platform-based product for minimally invasive surgeries in spine, joint, sports medicine, and trauma.

Moving forward, Zhuoxin Medical will continue to refine its products and optimize technical integration. Centered on its core offerings—the 3D C-arm and the orthopedic platform robot—the company will deepen the integration of intelligent imaging with surgical robotics, continuously enhance AI algorithms for preoperative planning and the precision of intraoperative real-time navigation, adapt to complex orthopedic surgical scenarios, and steadily elevate the clinical value of its products.

For a long time, county-level hospitals have been constrained by limited medical technology and equipment, often struggling to perform complex orthopedic surgeries. As a result, many patients have had to seek treatment in major cities, bearing the burden of high medical costs and the hardships of travel.

Professor Wang Shaobai introduced that orthopedic surgical robots and 3D C-arms, as high-quality medical devices with both technical value and multi-scenario application potential, can provide key support for the standardization of surgical procedures, the promotion and popularization of high-quality medical technologies, and the in-depth coverage of the primary healthcare market, by leveraging their intelligent, precise, and minimally invasive diagnostic and therapeutic capabilities. Integrating capabilities such as AI-powered intelligent decision support and 5G-enabled remote data collaboration further promotes the penetration of advanced diagnostic and therapeutic functions into primary healthcare settings, which is currently one of the key focuses of Zhuoxin Medical.

In the first half of 2025, under the leadership of Professor Fan Haiquan, a Level-1 Expert and Chief Physician in the Department of Orthopedics at the Second Affiliated Hospital of Chengdu Medical College, the orthopedic team from Cengong County People’s Hospital, led by Director Yao Maohui and Director Tian Jiageng, successfully performed robot-assisted percutaneous pedicle screw fixation for lumbar fracture using Zhuoxin Medical’s integrated smart imaging orthopedic solution.This is the first county-level hospital in China to implement an integrated intraoperative solution featuring a domestically developed 3D C-arm and spinal surgery robot., marking the official entry of the Department of Orthopedics at Cengong County People's Hospital into a new era of intelligent and precise diagnosis and treatment, and drawing a watershed moment for grassroots medical technological innovation in the hinterland of Qiandongnan.

During the procedure, the Zhuoxin Digital Intelligence Orthopedic Robot worked in close coordination with the 3D C-arm. It not only provided surgeons with clear and accurate 3D imaging and detailed visualization of the microstructure at the lumbar fracture site, but also effectively reduced the risk of injury to the patient’s nerves, blood vessels, and spinal cord through optimal screw implantation path planning and sub-millimeter operational precision, achieving a synergistic effect greater than the sum of its parts (1+1>2).

 Professor Fan Haiquan’s Team Performs Surgery Using the Zhuoxin Digital-Intelligent Orthopedic Robot and 3D C-arm

Currently, Zhuoxin Medical has leveraged technology to extend its reach to remote western regions such as Guizhou, enabling county-level hospitals to perform complex orthopedic surgeries. This approach reduces the traditional overreliance on surgeons’ experience, effectively enhances the level of orthopedic diagnosis and treatment at the county level, and promotes the equitable distribution of medical resources.

Zhuoxin Medical is rooted in the Chinese market, focusing on intelligent imaging and surgical robotics. Leveraging the high-quality platform resources provided by the G60 Shanghai Yangtze River Delta Medical Device Industry Development Promotion Association to support enterprises’ global expansion, Zhuoxin is accelerating its overseas deployment of Chinese-made medical equipment in Southeast Asia, the Middle East, and South America. The company is currently pursuing relevant medical device registrations in the European Union.

In promoting the localized innovation of orthopedic surgical robots, Zhuoxin Medical will continue to aim at “breaking the monopoly of imported brands in the high-end market,” leverage the iterative advantages of its open system tailored to domestic clinical needs, drive technological upgrades and market share growth for domestically produced orthopedic equipment, and foster the independent development of the medical device industry.

In the future, Zhuoxin Medical will continue to adhere to innovation-driven development and clinical application orientation, aiming to develop version 2.0 within one to two years to promote the R&D and upgrading of surgical robots and medical imaging equipment. Additionally, the company will achieve product diversification and application expansion. While maintaining its focus on orthopedics, it will strengthen its technological reserves in urology, general surgery, thoracic surgery, breast surgery, and respiratory medicine, thereby continuously expanding the application scenarios of its products.

Shanghai Lingang United Development Co., Ltd. is a subsidiary of Lingang Group, a large state-owned enterprise under the Shanghai Municipal State-owned Assets Supervision and Administration Commission (SASAC) that specializes in industrial park development, supporting services, and related industrial investments. It is a key component of the listed entity “Shanghai Lingang (600848).” As an important carrier for fostering biomedical innovation in the Yangtze River Delta region, Lingang United’s industrial parks consistently adhere to the principles of “specialization, systematic integration, and standardization” in providing industrial resource services to enterprises.

The industrial parks under the Lingang United Company have gathered more than 100 upstream and downstream enterprises in the medical device sector, covering well-known companies in fields such as high-value consumables, medical equipment, and in vitro diagnostics. The park has introduced the Shanghai Yangtze River Delta Medical Device Industry Development Promotion Association to provide one-stop services for policy interpretation and registration filing consultation. By integrating resources within and outside the group and the park, it offers enterprises convenient testing channels to address diverse testing needs during different stages, including research and development and registration filing.